How can Quad Countries Manage Biotech's Opportunities and Risks?
“For most countries, the capacity to undertake cuttingedge biotech research and development will be the most consequential variable in deciding how much of the biotech pie they get.”
In the latest paper from the QTN series, Dirk van der Kley from the School of Regulation and Global Governance, argues that biotechnology is set to be one of the most lucrative emerging technologies, offering an opportunity for Quad countries to cooperate on biotech standards, ethics, and joint research infrastructure.